This is a translation of the original article in Portuguese. Read the original (Português).
Hapvida, the Brazilian health plan operator, is negotiating the sale of loss-making assets, mainly in the South and Southeast regions of Brazil. The talks are at an early stage and involve investment managers such as Bain Capital, Advent, CVC Capital Partners and Mubadala, in addition to Amil, according to the newspapers O Globo and Valor Econômico.
One of the negotiations, according to the newspaper Estadão as cited by O Globo, covers eight hospitals, 21 clinics and more than 482,000 members. The deal is estimated at R$ 779 million.
Valor Econômico reports that the company is also negotiating the sale of the health plan operators Clinipam and Centro Clínico Gaúcho, valued at about R$ 1 billion. In the hospital segment, Hapvida has already sold the building of the Octaviano Neves Hospital in Belo Horizonte for R$ 60 million.
According to Valor, the Pinheiro family is resisting the idea of selling NotreDame Intermédica, another of the group’s brands. The company has free cash of R$ 5.3 billion, according to the newspaper.
The market reacted well to the move: according to O Globo, Hapvida’s shares rose 3.92% on the day.
For consumers, what is at stake is the fate of health plans and hospitals used by hundreds of thousands of people. A possible change of controlling shareholder could alter the network of accredited providers, the quality of care and monthly premium prices, but the details of how members’ contracts would look depend on agreements that have not yet been concluded.
The presence of private equity firms, funds that buy companies in order to reorganize them and resell them later, shows the interest of financial investors in the health sector. The South and Southeast regions, where the assets under negotiation are located, concentrate the members who could be affected.
Regulators still need to detail the rules and procedures that would apply to any transfers of customer portfolios and care units.
Reporting from O Globo (p. 21, São Paulo/SP), Valor Econômico (p. 28, São Paulo/SP).
Deixe um comentário